Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
deals
ipo
2
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
2
×
startups
venture capital
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
armo biosciences
astrazeneca
autoimmune
avalon ventures
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
clinical trials
coi pharmaceuticals
correlation ventures
covid-19
crispr
crohn's disease
cytokines
deerfield management
detroit blog main
What
ipo
plans
2
×
acquisitions
advance
announced
bio
biology
ceo
collabs
company
covid
cytokine
daniel
deal
drugs
enhanced
files
gilead
gilead’s
help
initial
introduce
laying
medicines
money
month
offering
o’day
public
raise
roundup
san
sciences
suite
synthetic
synthorx
transformative
years
Language
unset
Current search:
plans
×
" san francisco blog main "
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs